Federal Agency · Centers for Disease Control - NCEZID
Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
Posted May 19, 2026
Funding
$25K – $1M
Closes
June 19, 2026
NAICS
621
The purpose of this NOFO is to improved awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding. The NOFO strategies are to 1) SHARE - Formation of a network of AGS professionals to disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response.
Award details
Award range: $25K – $1M. Applications close on June 19, 2026 (7 days remaining).
Categories
Not categorized
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Jun 12, 2026
